Charlotte Summers

Professor Charlotte Summers serves as Director of the Victor Phillip Dahdaleh Heart & Lung Research Institute and Professor of Intensive Care Medicine at the University of Cambridge School of Clinical Medicine. An internationally recognized clinician-scientist, she leads transformative research bridging discovery science, clinical trials, and policy leadership to improve outcomes for patients with acute and critical illness.

Her educational background includes dual degrees in Biomedical Sciences and Medicine from the University of Southampton, followed by a PhD at Cambridge investigating pulmonary neutrophil kinetics. She pioneered as the UK’s first NIHR Clinical Lecturer in Intensive Care Medicine and received prestigious Fulbright and Wellcome Trust fellowships.

• Research Focus: Advancing acute care through pulmonary immunology, inflammation mechanisms in respiratory failure, and host defense systems. Her work spans laboratory investigations of neutrophil function to global clinical trials addressing health disparities.
• Current Emphasis: Understanding long-term post-COVID sequelae, ARDS pathophysiology, and developing novel interventions for critical illness across diverse healthcare settings.

Her publication trends reveal sustained contributions to pandemic response, with emphasis on global health equity, immunological mechanisms of respiratory failure, and methodological innovations in clinical trial design. Recent work increasingly addresses algorithmic bias in health AI and long-term recovery trajectories.

• NIHR Clinical Lecturer in Intensive Care Medicine
• Fulbright All-disciplines Scholar Award
• Wellcome Trust Fellowship for Postdoctoral Clinician Scientists

As mentor and leader, Summers supervises PhD students while directing major initiatives including HEAL-COVID (the largest NIHR-funded post-COVID trial) and GenOMICC. Her research receives substantial support from NIHR, MRC, and industry partners, with emphasis on translating discoveries into clinical practice through cross-sector collaboration.

She leads the Victor Phillip Dahdaleh Heart & Lung Research Institute’s experimental medicine programs, fostering international partnerships through ISARIC 4C and PHOSP-COVID. Her team integrates laboratory science with real-world clinical data to address critical gaps in acute respiratory care globally.